| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |